you are here: HomeNewsIndia

Over 36,000 ventilators delivered to govt hospitals amid COVID: Govt

The ministry underlined that all public health facilities in the country had only around 16,000 ventilators from the Independence till pre-COVID times.

December 31, 2020 / 03:02 PM IST

The Health Ministry said on Thursday that it had ensured delivery of 36,433 ventilators to government hospitals in the country and the average cost now ranges between Rs 2-10 lakh as the domestic industry took up manufacturing of the equipment.

The ministry underlined that all public health facilities in the country had only around 16,000 ventilators from the Independence till pre-COVID times.

But in less than 12 months, 36,433 'Make in India' ventilators have been supplied to all the public health facilities, it said in a statement.

All export restrictions on ventilators have now been removed and 'Make in India' ventilators are being exported. The year witnessed tremendous achievements in the medical supplies sector in the country, the ministry said.

"At the beginning of the pandemic, India was almost totally dependent on imported ventilators, PPE kits and N-95 masks," it said. "There were, in fact, no standard specifications for these products which are essential in the fight against the pandemic."

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The central government recognised the challenges posed by the pandemic in the very initial stages and successfully ensured more than adequate availability and supplies of essential medical items across the country, according to the ministry.

In the case of personal protective equipment (PPE), India has now become the world's second-largest manufacturer from a miniscule domestic production capacity in March. There is a production capacity of more than 10 lakh PPE coveralls per day and it is also exported to several countries, the ministry said.

There are already nearly 1,700 indigenous manufacturers and suppliers registered on the government e-marketplace, with dozens already certified by the Bureau of Indian Standards.

Nearly 1.7 crore lakh PPE kits have been distributed free of cost to the states, Union territories and central institutions.

"The buffer stock of PPE kits available with the central and state governments has grown from about 2 lakh in March to more than 89 lakh at present. The average price has come down substantially from nearly Rs 600 to about Rs 200 per kit in 9 months," the ministry said.

There were only three suppliers of N-95 masks with a production capacity of less than 1 lakh masks per day. Now over 3,000 manufacturers and suppliers, including 1,509 BIS-certified ones, of N-95 masks are already registered on the government portal and the domestic production capacity has risen to more than 8 lakh per day, it said.

These are also being exported from India in large quantities. More than 4 crore N-95 masks have so far been distributed free of cost to various states, Union territories and central institutions.

The buffer stock of N-95 masks available with the central and state governments has risen sharply from about 9 lakh in March to about 1.46 crore at present and the average prices have dropped from about Rs 40 to Rs 12 per mask during the same period,the ministry stated.

The government has already placed orders for procurement of nearly 83 crore syringes. Additionally, bids have also been invited for nearly 35 crore syringes. These will be used for COVID vaccination and also for the universal immunisation programme.
PTI
first published: Dec 31, 2020 02:58 pm

stay updated

Get Daily News on your Browser
Sections